Putting the Immunologic Brakes on Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30500529.
- Also identified by DOI 10.1016/j.cell.2018.11.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 2018 Nobel Prize in Medicine and Physiology has been awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. These insights have given rise to a class of medicines that have now entered routine use in the treatment of advanced cancers and have provided a foundation for additional exploration and discovery of pathways critical to modulating the immune response to cancer.
Medical subject headings
- Immunotherapy
- Neoplasms
- Nobel Prize